Question · Q4 2025
Gabriella Garr asked about Revolve's inventory positioning heading into 2026, noting that inventory grew roughly in line with sales in Q4 2025. She specifically inquired about the health of the inventory given faster-growing categories and shifts in product mix, such as the rapid growth of beauty sales.
Answer
CFO Jesse Timmermans expressed confidence in the inventory position, stating that the 10% year-over-year growth was in line with sales. He acknowledged a slight lag from Q3 supply chain difficulties but emphasized the overall health of the inventory, particularly for FWRD, which can take longer to work through. He also noted good positioning in other categories like beauty, indicating readiness for continued expansion.
Ask follow-up questions
Fintool can predict
RVLV's earnings beat/miss a week before the call